CoChat

Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Gallbladder cancer is the most common biliary tract malignant tumor with highly metastatic characters and poor prognosis. However, the underlying mechanism remains unclear. Stathmin1 is ubiquitous phosphoprotein, regulating microtubule stabilization. We identified the acetylation of stahtmin1 at lysine 9 (K9) in gallbladder cancer. K9 acetylation of stathmin1 was reversely regulated by the acetyltransferase PCAF and the deacetylases sirt2. K9 acetylation of stathmin1 inhibited the combining of stathmin1 to E3 ubiquitin ligase RLIM, thereby inhibiting its ubiquitination degradation. Moreover, K9 acetylation also promoted the activity of stahtmin1 interacting and destabilizing microtubule through the inhibition of stathmin1 phosphorylation. K9 acetylated stathmin1 significantly promoted gallbladder cancer cell migration and invasion viability in vitro and lung metastasis in vivo, and indicated poor prognosis of nude mice. IHC assay suggested the positive correlation of high levels of K9 acetylation and stathmin1 expression in gallbladder cancer. Our study revealed that K9 acetylation up-regulated stathmin1 protein stability and microtubule-destabilizing activity to promoted gallbladder cancer metastasis, which provides a potential target for gallbladder cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41420-022-01051-z

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Stathmin1 was acetylated at K9 in GBC. Immunoprecipitation detection of the acetylation of exogenous stathmin1, A, B after transfection of stathmin1-Flag plasmids to 293 T cells for 48 h with TSA and NAM treatment at indicated time, C, D in GBC-SD and SGC-996 stable cells with stathmin1 overexpression, E, F in GBC-SD and SGC-996 cells. G The amino acid sequence analysis around K9 in different of species. H Immunoprecipitation detection of the acetylation of exogenous stathmin1. Stathmin1WT-Flag, stathmin1K9R-Flag, stathmin1K29R-Flag, stathmin1K100R-Flag and stathmin1K119R-Flag plasmids were transfected to 293 T cells for 48 h with TSA and NAM treatment. Immunoprecipitation detection of K9 acetylation of exogenous stathmin1 through K9ac specific antibody, I after transfection of stathmin1WT-Flag and stathmin1K9R-Flag plasmids to 293 T cells for 48 h with NAM treatment, J in GBC-SD and SGC-996 stable cells overexpressing stathmin1, K, L in GBC-SD and SGC-996 cells. Results were shown as means ± s.d from at least three independent experiments.
Fig. 1 Stathmin1 was acetylated at K9 in GBC. Immunoprecipitation detection of the acetylation of exogenous stathmin1, A, B after transfection of stathmin1-Flag plasmids to 293 T cells for 48 h with TSA and NAM treatment at indicated time, C, D in GBC-SD and SGC-996 stable cells with stathmin1 overexpression, E, F in GBC-SD and SGC-996 cells. G The amino acid sequence analysis around K9 in different of species. H Immunoprecipitation detection of the acetylation of exogenous stathmin1. Stathmin1WT-Flag, stathmin1K9R-Flag, stathmin1K29R-Flag, stathmin1K100R-Flag and stathmin1K119R-Flag plasmids were transfected to 293 T cells for 48 h with TSA and NAM treatment. Immunoprecipitation detection of K9 acetylation of exogenous stathmin1 through K9ac specific antibody, I after transfection of stathmin1WT-Flag and stathmin1K9R-Flag plasmids to 293 T cells for 48 h with NAM treatment, J in GBC-SD and SGC-996 stable cells overexpressing stathmin1, K, L in GBC-SD and SGC-996 cells. Results were shown as means ± s.d from at least three independent experiments.CC BY · PubMed Central
Fig. 2 K9 acetylation inhibited the ubiquitination degradation to promote stathmin1 protein stability. Stathmin1 protein level was analyzed through western blot in GBC-SD and SGC-996 cells, A after NAM treatment, B, C after MG132 treatment at indicated time. D, E Western blot analysis of stathmin1 protein stability after NAM and CHX treatment. Immunoprecipitation analysis of ubiquitination of stathmin1, F after transfection of stathmin1-Flag and Ub-MYC plasmids to 293 T cells for 48 h, G with NAM treatment after plasmids transfection for 48 h, H with Stathmin1WT-Flag, Stathmin1K9R-Flag plasmids transfection and NAM treatment. Results were shown as means ± s.d from three independent experiments, *p < 0.05.
Fig. 2 K9 acetylation inhibited the ubiquitination degradation to promote stathmin1 protein stability. Stathmin1 protein level was analyzed through western blot in GBC-SD and SGC-996 cells, A after NAM treatment, B, C after MG132 treatment at indicated time. D, E Western blot analysis of stathmin1 protein stability after NAM and CHX treatment. Immunoprecipitation analysis of ubiquitination of stathmin1, F after transfection of stathmin1-Flag and Ub-MYC plasmids to 293 T cells for 48 h, G with NAM treatment after plasmids transfection for 48 h, H with Stathmin1WT-Flag, Stathmin1K9R-Flag plasmids transfection and NAM treatment. Results were shown as means ± s.d from three independent experiments, *p < 0.05.CC BY · PubMed Central
Fig. 3 K9 acetylation promoted the combination of stathmin1 and tubulin through inhibiting the phosphorylation of stathmin1. A Western blot detection of the ERK1/2 phosphorylation. The ERBB2WT-Flag, ERBB2S310F-Flag and vector plasmids were transfected to 293 T cells for 48 h. B Immunoprecipitation detection of the phosphorylation of stathmin1. The ERBB2WT-Flag, ERBB2S310F-Flag and vector plasmids were co-transfected with stathmin1-HA plasmids to 293 T cells for 48 h. Co-immunoprecipitation detection of the interaction of stathmin1 and tubulin, C after transfection of stathmn1-HA and ERBB2S310F-Flag plasmids to 293 T cells with NAM treatment, D, E in the ERBB2S310F overexpressed GBC-SD and SGC-996 stable cells with NAM treatment, F after transfection of stathmin1-Flag and tubulin-HA plasmids to 293 T cells for 48 h with NAM treatment, G after transfection of stathmin1WT-Flag, stathmin1K9R-Flag and tubulin-HA plasmids to 293 T cells for 48 h with NAM treatment, H, I in GBC-SD and SGC-996 stable cells with stathmin1 overexpression treated by NAM. Results were shown as means ± s.d, represented three independent experiments.
Fig. 3 K9 acetylation promoted the combination of stathmin1 and tubulin through inhibiting the phosphorylation of stathmin1. A Western blot detection of the ERK1/2 phosphorylation. The ERBB2WT-Flag, ERBB2S310F-Flag and vector plasmids were transfected to 293 T cells for 48 h. B Immunoprecipitation detection of the phosphorylation of stathmin1. The ERBB2WT-Flag, ERBB2S310F-Flag and vector plasmids were co-transfected with stathmin1-HA plasmids to 293 T cells for 48 h. Co-immunoprecipitation detection of the interaction of stathmin1 and tubulin, C after transfection of stathmn1-HA and ERBB2S310F-Flag plasmids to 293 T cells with NAM treatment, D, E in the ERBB2S310F overexpressed GBC-SD and SGC-996 stable cells with NAM treatment, F after transfection of stathmin1-Flag and tubulin-HA plasmids to 293 T cells for 48 h with NAM treatment, G after transfection of stathmin1WT-Flag, stathmin1K9R-Flag and tubulin-HA plasmids to 293 T cells for 48 h with NAM treatment, H, I in GBC-SD and SGC-996 stable cells with stathmin1 overexpression treated by NAM. Results were shown as means ± s.d, represented three independent experiments.CC BY · PubMed Central
Fig. 4 PCAF mediated the K9 acetylation of stathmin1. Immunoprecipitation detection of K9 acetylation of stathmin1, A after co-transfection of plasmids of PCAF-HA, CBP-HA, P300-HA and GCN5-HA with stathmin1-Flag plasmids to 293 T cells for 48 h, B after transfection of plasmids of stathmin1-Flag and PCAF-HA to 293 T cells with NAM treatment, C after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag and PCAF-HA to 293 T cells for 48 h, D after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag, PCAF-HA and Ub-MYC to 293 T cells for 48 h, E, F in GBC-SD and SGC-996 stable cells overexpressing stathmin1. (G) Western blot detection of stathmin1 protein level after PCAF knockdown by targeting siRNA, non-targeting siRNA as control. Immunoprecipitation detection of the phosphorylation and acetylation levels of stathmin1, H after transfection of plasmids of stathmin1-MYC, ERBB2S310F-Flag and PCAF-HA to 293 T cells for 48 h, I after transfection of plasmids of stathmin1-MYC, Tubulin-Flag and PCAF-HA to 293 T cells for 48 h, J, K in GBC-SD and SGC-996 stable cells after PCAF knockdown. Results were shown as means ± s.d with at least three independent experiments.
Fig. 4 PCAF mediated the K9 acetylation of stathmin1. Immunoprecipitation detection of K9 acetylation of stathmin1, A after co-transfection of plasmids of PCAF-HA, CBP-HA, P300-HA and GCN5-HA with stathmin1-Flag plasmids to 293 T cells for 48 h, B after transfection of plasmids of stathmin1-Flag and PCAF-HA to 293 T cells with NAM treatment, C after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag and PCAF-HA to 293 T cells for 48 h, D after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag, PCAF-HA and Ub-MYC to 293 T cells for 48 h, E, F in GBC-SD and SGC-996 stable cells overexpressing stathmin1. (G) Western blot detection of stathmin1 protein level after PCAF knockdown by targeting siRNA, non-targeting siRNA as control. Immunoprecipitation detection of the phosphorylation and acetylation levels of stathmin1, H after transfection of plasmids of stathmin1-MYC, ERBB2S310F-Flag and PCAF-HA to 293 T cells for 48 h, I after transfection of plasmids of stathmin1-MYC, Tubulin-Flag and PCAF-HA to 293 T cells for 48 h, J, K in GBC-SD and SGC-996 stable cells after PCAF knockdown. Results were shown as means ± s.d with at least three independent experiments.CC BY · PubMed Central
Fig. 5 Sirt2 mediated the deacetylation of stathmin1. Immunoprecipitation detection of K9 acetylation of stathmin1, A after co-transfection of plasmids of sirt1-HA, sirt2-HA, sirt3-HA and sirt5-HA with stathmin1-Flag to 293 T cells for 48 h, B after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag and sirt2-HA to 293 T cells for 48 h, C after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag, sirt2-HA and Ub-MYC to 293 T cells for 48 h. D, E Immunoprecipitation assay of ubiquitination of stathmin1 in GBC-SD and SGC-996 stable cells with sirt2 knockdown by targeting siRNA. F Western blot detection of stathmin1 protein and K9 acetylation levels. The siRNA targeting sirt2 was transfected to GBC-SD and SGC-996 cells for 48 h, nontargeting siRNA as control. G Immunoprecipitation detection of the phosphorylation and acetylation levels of stathmin1. The plasmids of stathmin1-MYC, ERBB2S310F-Flag and sirt2-HA were transfected to 293 T cells for 48 h. Co-immunoprecipitation detection of the interaction of stathmin1 and tubulin, H after transfection of plasmids of stathmin1-MYC, Tubulin-Flag and sirt2-HA to 293 T cells for 48 h, I, J in GBC-SD and SGC-996 stable cells after sirt2 knockdown. Results shown as means ± s.d represented at least three independent experiments.
Fig. 5 Sirt2 mediated the deacetylation of stathmin1. Immunoprecipitation detection of K9 acetylation of stathmin1, A after co-transfection of plasmids of sirt1-HA, sirt2-HA, sirt3-HA and sirt5-HA with stathmin1-Flag to 293 T cells for 48 h, B after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag and sirt2-HA to 293 T cells for 48 h, C after transfection of plasmids of stathmin1WT-Flag, stathmin1K9R-Flag, sirt2-HA and Ub-MYC to 293 T cells for 48 h. D, E Immunoprecipitation assay of ubiquitination of stathmin1 in GBC-SD and SGC-996 stable cells with sirt2 knockdown by targeting siRNA. F Western blot detection of stathmin1 protein and K9 acetylation levels. The siRNA targeting sirt2 was transfected to GBC-SD and SGC-996 cells for 48 h, nontargeting siRNA as control. G Immunoprecipitation detection of the phosphorylation and acetylation levels of stathmin1. The plasmids of stathmin1-MYC, ERBB2S310F-Flag and sirt2-HA were transfected to 293 T cells for 48 h. Co-immunoprecipitation detection of the interaction of stathmin1 and tubulin, H after transfection of plasmids of stathmin1-MYC, Tubulin-Flag and sirt2-HA to 293 T cells for 48 h, I, J in GBC-SD and SGC-996 stable cells after sirt2 knockdown. Results shown as means ± s.d represented at least three independent experiments.CC BY · PubMed Central
Fig. 6 K9 acetylation inhibited the combination of stathmin1 with RLIM. Immunoprecipitation detection of the interaction of stathmin1 and RLIM, A after transfection of plasmids of stathmin1-Flag and RLIM-HA to 293 T cells with MG132 treatment, B after transfection of plasmids of stathmin1-Flag and RLIM-HA to 293 T cells with MG132 and NAM treatment, C after transfection of plasmids of stathmin1-Flag, RLIM-HA and Ub-MYC to 293 T cells with NAM treatment, D, E in GBC-SD and SGC-996 stable cells with stathmin1 overexpression. F Western blot detection of stathmin1 protein level. The siRNAs targeting RLIM were transfected to GBC-SD and SGC-996 cells for 48 h, nontargeting siRNA as negative control. G Western blot detection of stathmin1 protein stability. GBC-SD cells were transfected by the siRNA targeting RLIM for 48 h, and treated by CHX. All results shown as means ± s.d represented at least three independent experiments.
Fig. 6 K9 acetylation inhibited the combination of stathmin1 with RLIM. Immunoprecipitation detection of the interaction of stathmin1 and RLIM, A after transfection of plasmids of stathmin1-Flag and RLIM-HA to 293 T cells with MG132 treatment, B after transfection of plasmids of stathmin1-Flag and RLIM-HA to 293 T cells with MG132 and NAM treatment, C after transfection of plasmids of stathmin1-Flag, RLIM-HA and Ub-MYC to 293 T cells with NAM treatment, D, E in GBC-SD and SGC-996 stable cells with stathmin1 overexpression. F Western blot detection of stathmin1 protein level. The siRNAs targeting RLIM were transfected to GBC-SD and SGC-996 cells for 48 h, nontargeting siRNA as negative control. G Western blot detection of stathmin1 protein stability. GBC-SD cells were transfected by the siRNA targeting RLIM for 48 h, and treated by CHX. All results shown as means ± s.d represented at least three independent experiments.CC BY · PubMed Central
Fig. 7 K9 acetylated stathmin1 promoted GBC metastasis. A, B Cell migration assay in SGC-996 and GBC-SD stable cells in vitro. C, D Cell invasion assay through coated transwell in SGC-996 and GBC-SD stable cells in vitro. SGC-996 and GBC-SD cells were employed to establish stable cells overexpressing wild type stathmin1 and K9R mutant stathmin1 with luciferase marker. The bar graph of transwell results shown as means ± s.d of five random fields with at least three independent experiments. Scale bar: 200 μm. E Live imaging detection of luciferase expression from pulmonary tumors in vivo. SGC-996 stable cells were seed to mice through tail intravenous injection for establishing the model of gallbladder cancer lung metastasis. The metastatic tumors were monitored every two weeks through Tanon ABL X5 Live Animal Imaging System. F Lungs images of both wild type stathmin1 and mutant stathmin1 groups resected from gallbladder cancer lung metastasis mice model. G Quantification of luciferase expression of pulmonary tumors. H Survival analysis of gallbladder cancer lung metastasis mice. I Upper: HE staining analysis of lung tissues. Lower: IHC analysis of K9 acetylation of stathmin1 and its protein levels in lung tissues of mice. GBC lung metastasis results in vivo shown as means ± s.d with six mice for each group. Scale bar: 200 μm.
Fig. 7 K9 acetylated stathmin1 promoted GBC metastasis. A, B Cell migration assay in SGC-996 and GBC-SD stable cells in vitro. C, D Cell invasion assay through coated transwell in SGC-996 and GBC-SD stable cells in vitro. SGC-996 and GBC-SD cells were employed to establish stable cells overexpressing wild type stathmin1 and K9R mutant stathmin1 with luciferase marker. The bar graph of transwell results shown as means ± s.d of five random fields with at least three independent experiments. Scale bar: 200 μm. E Live imaging detection of luciferase expression from pulmonary tumors in vivo. SGC-996 stable cells were seed to mice through tail intravenous injection for establishing the model of gallbladder cancer lung metastasis. The metastatic tumors were monitored every two weeks through Tanon ABL X5 Live Animal Imaging System. F Lungs images of both wild type stathmin1 and mutant stathmin1 groups resected from gallbladder cancer lung metastasis mice model. G Quantification of luciferase expression of pulmonary tumors. H Survival analysis of gallbladder cancer lung metastasis mice. I Upper: HE staining analysis of lung tissues. Lower: IHC analysis of K9 acetylation of stathmin1 and its protein levels in lung tissues of mice. GBC lung metastasis results in vivo shown as means ± s.d with six mice for each group. Scale bar: 200 μm.CC BY · PubMed Central
Fig. 8 K9 acetylation of stathmin1 were overexpressed in GBC tissues. A Western blot analysis of K9 acetylation of stathmin1 and the protein levels in five pairs of GBC and peritumor tissues. B–F Quantification of K9 acetylation of stathmin1, stathmin1, PCAF, sirt2 and RLIM levels in five pairs of GBC and peritumor tissues. The bar graph represented mean ± sd of five pairs of samples, *p < 0.05. G IHC analysis of K9 acetylation of stathmin1, stathmin1, PCAF and sirt2 and RLIM levels in 110 GBC samples and 50 peritumor tissues. Scale bar: 200 μm. H, I, K, M, N Quantification of K9 acetylation of stathmin1, stathmin1, PCAF, sirt2 and RLIM levels in GBC and peritumor tissues of IHC results. J and L Correlation analysis of K9 acetylation and stathmin1 protein levels, PCAF and stathmin1 protein levels in 110 GBC samples. The scatter graph represented mean ± sd, *p < 0.05. O A schematic diagram of K9 acetylation of stathmin1 promoting gallbladder cancer metastasis.
Fig. 8 K9 acetylation of stathmin1 were overexpressed in GBC tissues. A Western blot analysis of K9 acetylation of stathmin1 and the protein levels in five pairs of GBC and peritumor tissues. B–F Quantification of K9 acetylation of stathmin1, stathmin1, PCAF, sirt2 and RLIM levels in five pairs of GBC and peritumor tissues. The bar graph represented mean ± sd of five pairs of samples, *p < 0.05. G IHC analysis of K9 acetylation of stathmin1, stathmin1, PCAF and sirt2 and RLIM levels in 110 GBC samples and 50 peritumor tissues. Scale bar: 200 μm. H, I, K, M, N Quantification of K9 acetylation of stathmin1, stathmin1, PCAF, sirt2 and RLIM levels in GBC and peritumor tissues of IHC results. J and L Correlation analysis of K9 acetylation and stathmin1 protein levels, PCAF and stathmin1 protein levels in 110 GBC samples. The scatter graph represented mean ± sd, *p < 0.05. O A schematic diagram of K9 acetylation of stathmin1 promoting gallbladder cancer metastasis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 2

  1. Chen S, Zhao Y, Shen F, Long D, Yu T, Lin X. Introduction of exogenous wildtype p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factorkappaB in nonsmall cell lung cancer NCIH1299 cells. Oncol Rep. 2019;41:2051–9.
  2. Zhao Y, Chen S, Shen F, Long D, Yu T, Wu M, et al. In vitro neutralization of autocrine IL10 affects Op18/stathmin signaling in nonsmall cell lung cancer cells. Oncol Rep. 2019;41:501–11.

Cited by

See all 6

Metadata

Authors
Fan, K., Ni, X., Shen, S., Gong, Z., Wang, J., Xin, Y., Zheng, B., Sun, W., Liu, H., Suo, T., Ni, X., & Liu, H.
Affiliations
Shanghai Medical College of Fudan University (CN)
Corresponding author
  • Ni, Xiaoling
  • Liu, Houbao
Venue
Cell Death Discovery
Published
2022-05-17
Volume
8
Issue
1
Pages
265-265
ISSN
2058-7716 (ISSN-L)
OpenAlex
W4280491331
Cited by
6
References
39
Citations by year
2025: 3 · 2024: 1 · 2022: 2
FWCI
1.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death Discovery (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (81802751, 82072682)
  • Natural Science Foundation of Shanghai (22ZR1457800)
  • JianFeng Project of XuHui Provincial Commission of Health and Family Planning
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
Keywords
gallbladder cancer, metastasis, PCAF, SIRT2, RLIM, ubiquitination, protein stability, microtubule destabilization, cell migration and invasion, lung metastasis, prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis. https://app.cochat.ai/papers/10.1038/s41420-022-01051-z
The paper
Fan, K., Ni, X., Shen, S., Gong, Z., Wang, J., Xin, Y., Zheng, B., Sun, W., Liu, H., Suo, T., Ni, X., & Liu, H. (2022). Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis. Cell Death Discovery. https://doi.org/10.1038/s41420-022-01051-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.